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Purpose: To quantitatively compare hyperpolarized helium 3 (3He) 
and xenon 129 (129Xe) magnetic resonance (MR) images 
obtained within 5 minutes in healthy volunteers and pa-
tients with chronic obstructive pulmonary disease (COPD) 
and to evaluate the correlations between 3He and 129Xe 
MR imaging measurements and those from spirometry and 
plethysmography.
Materials and 
Methods:
This study was approved by an ethics board and compli-
ant with HIPAA. Written informed consent was obtained 
from all subjects. Eight healthy volunteers and 10 patients 
with COPD underwent MR imaging, spirometry, and pleth-
ysmography. Ventilation defect percentages (VDPs) at 3He 
and 129Xe imaging were obtained by using semiautomated 
segmentation. Apparent diffusion coefficients (ADCs) were 
calculated from 3He (b = 1.6 sec/cm2) and 129Xe (b = 12 
sec/cm2) diffusion-weighted images. VDPs at hyperpolarized 
3He and 129Xe imaging were compared with a two-tailed Wil-
coxon signed rank test and analysis of variance; Pearson cor-
relation coefficients were used to evaluate the relationships 
among measurements.
Results: 129Xe VDP was significantly greater than 3He VDP for patients 
with COPD (P , .0001) but not for healthy volunteers (P = 
.35), although 3He and 129Xe VDPs showed a significant correla-
tion for all subjects (r = 0.91, P , .0001). The forced expiratory 
volume in 1 second (FEV1) showed a similar and significant 
correlation with 3He VDP (r = 20.84, P , .0001) and 129Xe 
VDP (r = 20.89, P , .0001), although the correlation between 
the FEV1/forced vital capacity (FVC) ratio and 
129Xe VDP (r = 
20.95, P , .0001) was significantly greater (P = .01) than that 
for FEV1/FVC and 
3He VDP (r = 20.84, P , .0001). A signifi-
cant correlation was also observed for 3He and 129Xe ADC (r = 
0.97, P , .0001); 129Xe ADC was significantly correlated with 
diffusing capacity of lung for carbon monoxide (r = 20.79, P 
= .03) and computed tomographic emphysema measurements 
(areas with attenuation values in the 15th percentile: r = 20.91, 
P = .0003; relative areas with attenuation values of less than 
2950 HU: r = 0.87, P = .001).
Conclusion: In patients with COPD, the VDP obtained with hyperpolarized 
29Xe MR imaging was significantly greater than that with 3He 
MR imaging, suggesting incomplete or delayed filling of lung 
regions that may be related to the different properties of 129Xe 
gas and physiologic and/or anatomic abnormalities in COPD.
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(39,40). These important results sug-
gested that 129Xe MR imaging may be 
very useful for examining structural 
and functional abnormalities in COPD 
and generated numerous hypotheses to 
test. In this investigation, we hypoth-
esized that the different properties of 
129Xe gas would result in significant 
differences in the ventilation defect 
percentage (VDP) obtained with 129Xe 
compared with 3He in patients with 
COPD but not in healthy volunteers. 
Accordingly, our objective was to quan-
titatively compare hyperpolarized 3He 
and 129Xe MR images obtained within 
5 minutes in healthy volunteers and pa-
tients with COPD and to evaluate the 
correlations between 3He and 129Xe MR 
imaging measurements and those from 
spirometry and plethysmography.
Materials and Methods
Subjects
All subjects provided written informed 
consent to the study protocol, which 
was approved by the local research 
pulmonary images (1–4). Hyperpolarized 
3He MR imaging has dominated for the 
evaluation of gas distribution and tissue 
abnormalities in healthy volunteers (5); 
patients with chronic obstructive pul-
monary disease (COPD) (6–9), asthma 
(10–14), cystic fibrosis (15–18), and 
radiation-induced lung injury (19,20); 
and lung transplant recipients (21,22). 
Numerous studies have shown that 3He 
MR imaging in COPD is highly reproduc-
ible (6,23–25), is sensitive to early lung 
microstructural changes (1,26–31), and 
shows significant correlation with estab-
lished measurements of pulmonary func-
tion (1,32)—multisection computed to-
mography (CT) measurements (32) and 
histologic measurements of emphysema 
(33). Furthermore, longitudinal 3He MR 
imaging of COPD has highlighted the 
sensitivity of the method to progressive 
worsening (8,34) and shown regional 
improvements after bronchodilator use 
(35,36).
Unfortunately, despite the unique 
potential of 3He MR imaging, clinical 
translation has not occurred in part 
because of limited and unpredictable 
global quantities and high cost. 129Xe 
gas, conversely, is substantially more 
abundant in nature, existing in mea-
surable quantities in the atmosphere, 
and is relatively inexpensive. Although 
hyperpolarized 129Xe MR imaging is 
technically challenging because of its 
nearly threefold lower gyromagnetic ra-
tio and lower enrichment, considerable 
improvements in 129Xe gas polarization 
and imaging methods (37) have been 
achieved since the first clinical studies 
were reported (38–40). Recently, the 
tolerability of a 1.0-L inhaled dose of 
129Xe and diffusion-weighted MR imag-
ing measurements were reported in pa-
tients with COPD and healthy subjects 
Magnetic resonance (MR) imaging with use of hyperpolarized noble gases such as helium 3 (3He) and 
xenon 129 (129Xe) provides a way to ac-
quire high spatial and temporal resolution 
Implication for Patient Care
 n Differences between VDPs 
obtained at 129Xe and 3He MR 
imaging in COPD may reflect dif-
ferences in the properties of the 
gases and physiologic and/or an-
atomic abnormalities in COPD 
that are not seen in healthy 
volunteers.
Advances in Knowledge
 n For healthy volunteers and 
patients with COPD who under-
went both helium 3 (3He) and 
xenon 129 (129Xe) MR imaging 
within approximately 5 minutes, 
there were significant and strong 
correlations between 129Xe and 
3He ventilation defect percent-
ages (VDPs) (r = 0.91, P , 
.0001); however, for patients 
with COPD, the VDP with 129Xe 
MR imaging was significantly 
greater than that with 3He MR 
imaging (P , .0001).
 n There was a similar and strong 
correlation between VDPs 
obtained with 129Xe and 3He im-
aging and forced expiratory 
volume in 1 second (FEV1), but 
the relationship between 129Xe 
imaging–derived VDP and the 
FEV1/forced vital capacity ratio 
(r = 2.95, P , .0001) was signifi-
cantly stronger than that for 3He 
imaging–derived VDP (P = .01).
 n There were also significant and 
strong correlations between ap-
parent diffusion coefficients 
(ADCs) obtained with 3He and 
those obtained with 129Xe (r = 
.97, P , .0001), and both mea-
surements were significantly dif-
ferent in healthy subjects and 
patients with COPD (P , .001).
 n In all subjects, 129Xe imaging–
derived ADC was significantly 
correlated with diffusing capacity 
of lung for carbon monoxide (r = 
2.93, P , .0001); for patients 
with COPD, there were signifi-
cant correlations with CT mea-
surements of emphysema (areas 
with attenuation values in the 
15th percentile: r = 2.91, P = 
.0003; relative areas with attenu-
ation values of less than 2950 
HU: r = .87, P = .001).
Published online before print
10.1148/radiol.12120485 Content code: 
Radiology 2012; 265:600–610
Abbreviations:
ADC = apparent diffusion coefficient
COPD = chronic obstructive pulmonary disease
DLCO = diffusing capacity of lung for carbon monoxide
DW = diffusion weighted
FEV1 = forced expiratory volume in 1 second
FVC = forced vital capacity
ROI = region of interest
SNR = signal-to-noise ratio
3D = three-dimensional
2D = two-dimensional
VDP = ventilation defect percentage
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obtained by using a two-dimensional (2D) 
fast gradient-recalled echo sequence with 
centric phase-encoding ordering. Two in-
terleaved images (total data acquisition 
time = 16 seconds, 13.5/10, 9° flip angle, 
31.25-kHz bandwidth, 40 3 40-cm field 
of view, 128 3 80 matrix, seven sections; 
30-mm-thick sections, no gap), with and 
without additional diffusion sensitization 
with b = 12 sec/cm2 (maximum gradient 
amplitude = 2.90 G/cm, gradient rise and 
fall time = 0.5 msec, gradient separation 
= 2 msec, gradient duration = 2.0 msec, 
diffusion time = 5 msec). The diffusion 
time of 5 msec for 129Xe MR imaging 
was selected on the basis of the theo-
retical background for optimal gradient 
sequence parameters (45) and previous 
findings demonstrating its sensitivity to 
alveolar enlargement (46). All imaging 
was completed within approximately 5 
minutes of subjects first lying in the MR 
unit. In addition, based on the calcula-
tions for the theoretical diffusion coeffi-
cients for 3He and 129Xe and the diffusion 
times used, the characteristic diffusion 
length for 3He (~490 mm) is comparable 
to that for 129Xe (~460 mm), indicating 
that similar spatial length scales are being 
investigated.
Computed tomography (CT) was 
performed with a 64-section unit 
(Lightspeed VCT; GE Healthcare, Mil-
waukee, Wis) by using a detector con-
figuration of 64 3 0.625 mm, 120 kVp, 
effective tube current of 100 mA, tube 
rotation time of 500 msec, and pitch of 
1.0. A single spiral acquisition of the 
entire lung was acquired from the apex 
to the base with subjects in the supine 
position and with breath holding after 
inhalation of a 1.0-L Tedlar bag of N2 
from functional residual capacity. Re-
construction of the data was performed 
by using a section thickness of 1.25 mm 
with a standard convolution kernel.
Image Analysis
Semiautomated segmentation of 3He 
and 129Xe MR images was performed, 
similar to approaches that have been 
previously described for quantification 
of lung volumes (47), by using cus-
tom software generated with Matlab 
R2007b (Mathworks, Natick, Mass), 
as previously described (48). 3He MR 
Conventional hydrogen 1 (1H) MR 
imaging was performed before hyper-
polarized 129Xe and 3He MR imaging, 
with subjects imaged during 1.0-L 
breath hold of ultra–high purity medical 
grade nitrogen 2 (N2) (Spectra Gases, 
Alpha, NJ) by using a whole-body ra-
diofrequency coil and a 1H fast spoiled 
gradient-recalled echo sequence as pre-
viously described (6). Theoretical dif-
fusion coefficients for the 3He-N2 and 
129Xe-4He 50/50 mixtures were gener-
ated, adopting assumptions previously 
described (Appendix E1 [online]) (42).
Hyperpolarized 3He MR imaging 
was enabled by using a linear birdcage 
transmit-receive chest coil (Rapid Bio-
medical, Wuerzburg, Germany). A 
turnkey system (HeliSpin, GE Health-
care) was used to polarize 3He gas to 
30%–40%, and doses of 5 mL per ki-
logram of body weight, diluted with N2, 
were administered in 1.0-L Tedlar bags. 
Hyperpolarized coronal static venti-
lation 3He MR images and diffusion-
weighted (DW) images were acquired 
during breath hold of a 1.0-L 3He-N2 
mixture as previously described (6).
Hyperpolarized 129Xe MR imaging 
was enabled by using a custom-made, 
unshielded quadrature-asymmetric bird-
cage coil model tuned to 35.34 MHz, 
similar to previous approaches (43) and 
as previously described (44). 129Xe gas 
(86% enriched) was polarized to 10%–
60% by using a turnkey polarizer system 
(XeBox-E10; Xemed, Durham, NH). 
Doses of hyperpolarized 129Xe gas were 
dispensed directly into the prerinsed 1.0-
L Tedlar bags prefilled with 4He to gener-
ate a 50/50 mixture. Polarization of the 
diluted dose was quantified with use of 
a Polarimeter (GE Healthcare, Durham, 
NC). Coronal static ventilation images 
were acquired by using a three-dimen-
sional (3D) fast gradient-recalled echo 
sequence with centric phase-encoding 
ordering in the y direction and normal 
sampling in the z direction during breath 
hold of the 1.0-L 129Xe-4He mixture 
(data acquisition time = 14 seconds, 
repetition time msec/echo time msec = 
6.7/1.50, variable flip angle, 15.63-kHz 
bandwidth, 40 3 40-cm field of view, 
128 3 128 matrix, 14 sections, 15-mm-
thick sections, no gap). DW images were 
ethics board and Health Canada, and 
the study was compliant with the Per-
sonal Information Protection and Elec-
tronic Documents Act of Canada and 
the Health Insurance Portability and 
Accountability Act of the United States. 
Patients with COPD ranged in age from 
50 to 85 years and were ex-smokers 
with a smoking history of at least 10 
pack-years. A pack-year was defined as 
the number of cigarette packs smoked 
per day multiplied by the number of 
years smoked. Healthy volunteers 
were enrolled if they had no history of 
chronic or current respiratory disease. 
The mean age of all subjects (6stan-
dard deviation) was 71 years 6 8. Men 
had a mean age of 71 years 6 9, and 
women had a mean age of 72 years 6 6.
Pulmonary Function Tests
Spirometry was performed by using an 
EasyOne spirometer (ndd Medizintech-
nik, Zurich, Switzerland) according to 
American Thoracic Society guidelines 
(41). Static lung volumes and diffusing 
capacity of lung for carbon monoxide 
(DLCO) were measured by using body 
plethysmography (MedGraphics, St 
Paul, Minn).
Image Acquisition
MR imaging was performed with a 
whole-body 3.0-T unit (Discovery 
750MR; GE Healthcare, Milwaukee, 
Wis) with broadband imaging capabil-
ity, as previously described (6). Sub-
jects were instructed to inhale a gas 
mixture from a 1.0-L Tedlar bag (Jen-
sen Inert Products, Coral Springs, Fla) 
from functional residual capacity, and 
image acquisition was performed in 
8–15 seconds under breath-hold condi-
tions. It is important to note that we en-
deavored to minimize the potential for 
differences in the levels of inspiration 
between the breath-hold images for 
each subject by (a) conducting training 
and practice sessions for all subjects 
before MR imaging related to the in-
spiration breath-hold maneuver from 
functional residual capacity and (b) 
continuous coaching and monitoring at 
the MR imaging table by a pulmonary 
function technologist during all inspira-
tion breath-hold acquisitions.
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where ZHe is the z9 of rHe, ZXe the z9 of 
rXe, and n the number of subjects com-
pared. A Holm-Bonferroni correction 
(53) was used for multiple paired t 
tests and all correlations. The Holm-
Bonferroni–adjusted P values were 
determined by ordering P values from 
smallest to largest, with the smallest P 
value multiplied by k, where k is the 
number of hypotheses to be tested. If 
the resulting modified P value was less 
than a (type I error rate), the hypo-
thesis was rejected. The next smallest 
P value was then multiplied by k 2 1 
and the new modified P value compared 
with a. This process was repeated until 
the modified P value could not be re-
jected. In all statistical analyses, results 
were considered significant when the 
probability of making a type I error was 
less than 5% (P , .05).
Results
All imaging procedures and maneuvers 
were well tolerated, and no serious 
or severe adverse events were report-
ed. There was a single adverse event 
reported by one patient with COPD 
(headache 7 hours after completion 
of MR imaging that resolved without 
treatment), and this was judged to be 
unrelated to 3He or 129Xe gas inhala-
tion; the details of the safety and tol-
erability of 129Xe MR imaging for this 
study are reported elsewhere (54), and 
the tolerability of a 1.0-L 129Xe dose (vs 
the 50/50 mixture used herein) was 
previously reported (40). Table 1 shows 
demographic characteristics and pul-
monary function measurements for the 
eight healthy volunteers and 10 patients 
with COPD. One patient had Global 
Initiative for Chronic Obstructive Lung 
Disease (GOLD) class I, six patients 
had GOLD class II, two patients had 
GOLD class III, and one patient had 
GOLD class IV (55). The two subject 
groups were significantly different with 
respect to FEV1, FEV1/FVC ratio, re-
serve volume, ratio of reserve volume 
to total lung capacity, inspiratory ca-
pacity, functional residual capacity, and 
DLCO; there were no significant differ-
ences between the groups with respect 
to age, sex, or body mass index.
single SNR value for each subject. CT 
measurements were performed by us-
ing Matlab R2007b; the relative areas 
with attenuation values of less than 
2950 HU and areas with attenuation 
values in the 15th percentile were gen-
erated from the frequency distribution 
of Hounsfield units.
Statistical Methods
Multivariate analysis of variance and 
one-way analysis of variance were per-
formed with software (IBM SPSS Statis-
tics 20.0; SPSS, Chicago, Ill). A paired 
two-tailed t test was used for statistical 
comparison for normally distributed 
data, and a two-tailed Wilcoxon signed 
rank test was used for statistical com-
parison for nonnormally distributed 
data for tests between 3He and 129Xe 
VDP, ADC, and SNR by using software 
(Prism, version 4.00; GraphPad Soft-
ware, San Diego, Calif). Normality was 
determined with a Shapiro-Wilk test by 
using IBM SPSS Statistics 20.0. Two-
way mixed-effects repeated measures 
analysis of variance was used to de-
termine the interactions for VDP mea-
sured at both 3He and 129Xe MR imag-
ing and imaging section by using IBM 
SPSS Statistics 20.0. The agreement 
between VDP measurements obtained 
at 3He and 129Xe imaging was evaluated 
with Bland-Altman plots (51) generated 
by GraphPad software (Prism, version 
4.00). Linear regression (r2 values) 
and Pearson correlation coefficients 
(r values) were used to determine the 
relationships between imaging and 
other measurements by using software 
(Prism, version 4.00). Correlation coef-
ficients were compared (52) by calcu-
lating the Fisher z9 transformation for 
each r value, as follows:
′ = + − −1[log(1 ) log(1 )],
2
z r r
where r is the correlation coefficient for 
3He or 29Xe MR imaging (rHe and rXe, 
respectively). The Z value was then cal-
culated as follows:
−=
−
,
1
3
He Xez zZ
n
imaging of COPD is typically character-
ized by heterogeneous signal intensity 
that reflects gas distribution hetero-
geneity during inspiration breath-hold 
imaging. To compare the distribution 
of both 3He and 129Xe gases within the 
lung, we segmented the 3He and 129Xe 
images on the basis of pixel signal in-
tensity. Briefly, 3He and 129Xe static 
ventilation MR images were segmented 
by using a k-means approach (49) in 
which voxel intensity values are classi-
fied into five clusters ranging from sig-
nal void (cluster 1 or ventilation defect 
volume) and hypointense signal (cluster 
2 or partial volume) to hyperintense 
signal (cluster 5), therefore generat-
ing a gas distribution cluster map. For 
delineation of the ventilation defect 
boundaries, a seeded region-growing 
algorithm (50) was used to segment the 
1H MR images of the thoracic cavity for 
registration to the cluster map and 3He 
and 129Xe VDPs (7) were generated by 
using ventilation defect volume normal-
ized to the thoracic cavity volume. 3He 
and 129Xe non-DW images were also 
segmented by using the same approach, 
where non-DW images were segmented 
by using k-means cluster analysis and 
registered to the corresponding 1H MR 
imaging sections to calculate VDP (49). 
Apparent diffusion coefficient (ADC) 
analysis was performed as previously 
described (36). The signal-to-noise ra-
tio (SNR) for all 3He and 129Xe static 
ventilation and non-DW and DW im-
ages was determined by calculating the 
mean voxel value within a 5 3 5-cm2 
voxel region of interest (ROI) for four 
representative ROIs within the lung pa-
renchyma and dividing it by the stan-
dard deviation of the voxel values for 
noise inside four representative ROIs 
of the same size within the image 
background, where there was no lung 
structure. The ROIs within the lung pa-
renchyma and the image background 
were selected independently for each 
section, with the exception of DW im-
aging, where the ROIs were selected 
independently for each non-DW image 
section, and the coordinates of the lung 
ROI were applied to the DW image sec-
tion. The SNR was determined for each 
section and then averaged to obtain a 
604 radiology.rsna.org n Radiology: Volume 265: Number 2—November 2012
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and the difference between 3He and 
129Xe VDP (r = 0.26, P = .30).
As shown in Table 2, whole lung 
hyperpolarized 3He and 129Xe ADC was 
significantly different for the healthy 
volunteers (P = .002) and the patients 
with COPD (P , .0001). The mean 
SNRs were 36 6 16 and 64 6 29 for 
DW and non-DW 3He MR imaging, re-
spectively, and 11 6 6 and 28 6 19 for 
DW and non-DW 129Xe MR imaging.
Table 3 shows Pearson correlations 
between 3He and 129Xe VDP and ADC 
and pulmonary function measurements. 
There were significant and similar cor-
relations for 3He and 129Xe MR imaging 
VDP with FEV1, although the relation-
ship between VDP and FEV1/FVC was 
significantly stronger for 129Xe MR im-
aging (P = .01). There were also signif-
icant and similar correlations for 3He 
and 129Xe MR imaging ADC and DLCO 
(Table 3). Figure 3 shows the significant 
and strong relationships for 3He and 
129Xe ADC with relative areas with at-
tenuation values of less than 2950 HU 
(r = 0.90, P = .0005) and areas with 
measurements, we compared 3He and 
129Xe VDPs measured from non-DW 
images acquired with 2D fast gradient-
recalled echo sequences. No significant 
difference was observed between 129Xe 
VDPs obtained with 3D acquisition and 
those measured from non-DW images 
for the healthy volunteers and patients 
with COPD (P = .87). 3He VDPs ob-
tained with 2D acquisition were not 
significantly different from those mea-
sured from non-DW images for healthy 
volunteers (P = .50); however, they 
were significantly different for patients 
with COPD (P = .002). This result is 
in agreement with the 2D 3He and 3D 
129Xe MR imaging results that showed 
there was no difference between 3He 
and 129Xe VDPs for healthy volunteers 
but that 129Xe VDP was significantly 
greater than 3He VDP for patients with 
COPD. Mean SNR was significantly 
lower for 129Xe MR imaging (33 6 17) 
than for 3He MR imaging (56 6 25) (P 
, .0001); however, importantly, there 
was no significant correlation for the 
difference between 3He and 129Xe SNR 
Figure 1 shows coronal 3He and 
129Xe MR images for the two central 
sections, where the trachea and two 
main bronchi are clearly visible, with 
3He gas distribution displayed in red 
and 129Xe gas distribution displayed in 
purple. The 3He and 129Xe MR images 
are registered to the gray-scale 1H MR 
images of the thorax for three repre-
sentative healthy volunteers and three 
patients with COPD. For patients with 
COPD, regions of signal void are ob-
served on 129Xe MR images but are not 
qualitatively apparent on 3He MR im-
ages; these regions are readily observed 
in the right mid-apical region in one 
volunteer and in the right and left api-
cal regions in the other two volunteers.
Figure 2 shows the strong and sta-
tistically significant correlations be-
tween whole-lung 3He and 129Xe VDP (r 
= 0.91, P , .0001) and 3He and 129Xe 
ADC (r = 0.97, P , .0001). Although 
VDPs at 3He and 129Xe imaging showed 
significant correlation, Bland-Altman 
analysis indicates that there was a 9% 
6 8 bias (95% limit of agreement: 
225% to 7%) for higher VDP for 129Xe 
MR imaging. Table 2 shows mean gas 
distribution and ADC measurements 
for 3He and 129Xe MR imaging. The 
VDP obtained with 129Xe imaging was 
significantly greater than that with 3He 
imaging for the patients with COPD (P 
= .0003, uncorrected; P = .03, Holm-
Bonferroni corrected), and 129Xe sig-
nal intensity cluster 3 was significantly 
different (P = .002, uncorrected; P = 
.002, Holm-Bonferroni corrected). For 
healthy volunteers, there was no signifi-
cant difference between 129Xe VDP and 
3He VDP (P = .56); however, there was 
a significant difference in cluster 4 (P 
= .008, uncorrected). With Holm-Bon-
ferroni correction, however, this differ-
ence was no longer significant (P = .06). 
For both groups, there was no relation-
ship between the difference in 3He and 
129Xe VDPs and image section (P = 
.99), indicating no bias for differences 
between 3He and 129Xe VDP for any 
specific image section. To better under-
stand the potential effect of any differ-
ence in pulse sequence parameters for 
129Xe (3D acquisition) and 3He (2D ac-
quisition) MR imaging gas distribution 
Table 1
Summary of Demographics
Parameter* Healthy Volunteers (n = 8) Patients with COPD (n = 10) P Value†
Mean age (y) 67 (10) 74 (4) .10
 Men 63 (11) 75 (4)
 Women 71 (7) 73 (6)
No. of men 4 8 .32
BMI (kg/m2) 25.9 (2.2) 25.4 (5.0) .79
Pack-years 0 (0) 62 (15) NA
FEV1
‡ 107 (13) 57 (24) ,.001
FVC‡ 106 (13) 91 (19) .08
FEV1/FVC 0.75 (0.04) 0.46 (0.14) ,.0001
TLC‡ 106 (11) 115 (8) .09
RV‡ 105 (19) 159 (46) .007
RV/TLC‡ 0.39 (0.10) 0.53 (0.14) .03
IC‡ 120 (25) 85 (31) .02
FRC‡ 95 (13) 141 (35) .002
DLCO
‡ 103 (13) 41 (17)§ ,.0001
Note.—Numbers in parentheses are standard deviations.
* BMI = body mass index, FRC = functional residual capacity, IC = inspiratory capacity, RV = reserve volume, TLC = total lung 
capacity.
† Significant difference between groups (P , .05) was determined by using multivariate analysis of variance. The Fisher exact 
test was performed for categorical variables. NA = not applicable.
‡ Data are percentage predicted values.
§ Available for seven patients.
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Figure 1
Figure 1: Static ventilation 3He and 129Xe MR images in three healthy volunteers and three patients with COPD. Images of the two coro-
nal center sections, where trachea and two main bronchi are clearly visible, are registered to grayscale 1H MR images of thorax. Volun-
teer in S1 is 75-year-old woman with percentage predicted FEV
1
 of 93% and FEV
1
/FVC of 70%; volunteer in S2 is 57-year-old man with 
percentage predicted FEV
1
 of 95% and FEV
1
/FVC of 72%; volunteer in S3 is 51-year-old man with percentage predicted FEV
1
 of 120% 
and FEV
1
/FVC of 83%. Patient in S1 is 77-year-old woman with percentage predicted FEV
1
 of 50% and FEV
1
/FVC of 20%; patient in S2 
is 68-year-old woman with percentage predicted FEV
1
 of 59% and FEV
1
/FVC of 53%; patient in S3 is 71-year-old man with percentage 
predicted FEV
1
 of 107% and FEV
1
/FVC of 58%. 3He gas distribution is displayed in red and 129Xe gas distribution is displayed in purple.
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of which showed similar and significant 
correlations with DLCO and CT measure-
ments of emphysema.
First, in patients with COPD, the 
gas distribution at 129Xe MR imaging 
was qualitatively more regionally het-
erogeneous than that at 3He MR imag-
ing. This was not the case in healthy 
volunteers, where 129Xe and 3He MR 
imaging showed homogeneous gas 
distribution and very low VDPs that 
were not significantly different. The 
visually obvious differences between 
129Xe and 3He were also quantitatively 
different, with 129Xe VDP significantly 
greater (worse) than 3He VDP in pa-
tients with COPD but not in healthy 
minutes in healthy subjects and in pa-
tients with COPD and made the fol-
lowing observations: (a) significant and 
strong correlations were observed be-
tween VDPs obtained at 3He and 129Xe 
MR imaging, although visually and quan-
titatively VDPs obtained with 129Xe MR 
imaging were worse than those obtained 
with 3He MR imaging in patients with 
COPD but not in healthy subjects; (b) 
significant and strong correlations were 
observed that were similar for 3He and 
129Xe VDPs with FEV1 but significantly 
stronger between 129Xe VDP and FEV1/
FVC; and (c) a significant and strong 
correlation was observed between 
ADCs obtained with 3He and 129Xe, both 
attenuation values in the 15th percen-
tile (r = 20.91, P = .0003) for patients 
with COPD only.
Theoretical diffusion coefficients 
were generated as previously described 
(42) for 3He-N2 and 
129Xe-4He and are 
summarized in Table E1 (online). The 
3He-N2 diffusion coefficient in air for 
3He-N2 was 0.826 cm
2/sec, whereas the 
diffusion coefficient in air for 129Xe-4He 
was 0.211 cm2/sec and the self-diffusion 
coefficient of air was 0.218 cm2/sec.
Discussion
We evaluated 3He and 129Xe MR im-
ages acquired within approximately 5 
Figure 2
Figure 2: Graphs show relationship between VDP and ADC obtained at 3He and 129Xe MR imaging. A, 3He VDP shows 
significant and positive correlation with 129Xe VDP (r = 0.91, P , .0001; r2 = 0.82, P , .0001; y = 1.4 3 +2.7). Dashed lines 
= 95% confidence intervals of regression line. B, Mean bias (6standard deviation) between 3He and 129Xe VDP is 29% 6 8 
(lower limit = 225%, upper limit = 7%). Solid line = mean difference, dashed lines = 95% limits of agreement. C, 3He ADC 
shows significant and positive correlation with 129Xe ADC (r = 0.97, P , .0001; r2 = 0.93, P , .0001; y = 0.11 3 +0.03). 
Dashed lines = 95% confidence intervals of regression line.
Table 2
3He and 129Xe MR Imaging Measurements
Parameter
Healthy Volunteers (n = 8) Patients with COPD (n = 10)
3He MR Imaging* 129Xe MR Imaging* P Value† 3He MR Imaging* 129Xe MR Imaging* P Value† 
Gas distribution (%)
 VDP 4 (2) 4 (4) .56 (.99) 20 (10) 34 (13) .003 (.03)
 Cluster 2 10 (1) 11 (5) .94 (.94) 14 (2) 15 (3) .30 (.99)
 Cluster 3 36 (5) 26 (10) .08 (.48) 34 (5) 22 (6) .002 (.002)
 Cluster 4 34 (2) 40 (2) .008 (.06) 23 (7) 20 (9) .05 (.35)
 Cluster 5 16 (5) 19 (3) .22 (.99) 10 (4) 9 (4) .50 (.99)
ADC (cm2/sec) 0.246 (.021) 0.053 (.002) ‡ .002 (.02) 0.481 (.121) 0.079 (.015) ,.0001 (.001)
* Numbers in parentheses are standard deviations.
† Significant difference between groups (P , .05) was determined by using a two-tailed Wilcoxon signed rank test for gas distribution measurements and a two-tailed paired t test for ADC 
measurements. Numbers in parentheses are Holm-Bonferroni–adjusted P values.
‡ Available for three subjects.
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volunteers. Importantly, these differ-
ences could not be attributed to differ-
ences in the pulse sequences used, nor 
was there a bias detected for specific 
anterior-posterior sections dominating 
this result. This unexpected result leads 
to the simple question: Why are these 
measurements different in COPD? 
Some explanations might derive from 
the different gases themselves. In 
COPD, significant airflow limitation 
is thought to occur in small conduct-
ing airways less than 2 mm in diame-
ter (56), increasing airway resistance 
with the potential for regional and 
preferential 129Xe gas limitation to the 
distal airways. Another important con-
sideration relates to the terminal and 
respiratory bronchioles, where diffu-
sion dominates, and the lower diffusion 
coefficient of 129Xe relative to 3He may 
result in slower gas movement into the 
distal diseased lung regions. Another 
important consideration is the role of 
collateral ventilation in COPD. The 
lower atomic mass and higher diffusiv-
ity of 3He relative to 129Xe may allow for 
regions of lung that are not ventilated 
to gradually fill with 3He over the time 
course of breath-hold imaging, as has 
been shown recently by Marshall et al 
(57). Our finding that VDP was greater 
for 129Xe MR imaging than for 3He MR 
imaging, with both 3D and 2D image 
acquisition, suggests that the lower dif-
fusivity of 129Xe may slow the process 
of delayed and/or collateral ventilation 
Table 3
Relationships between 3He and 129Xe MR Imaging Parameters and Pulmonary Function Measurements
Pulmonary Function  
Measurement
3He MR Imaging 129Xe MR Imaging
VDP (%) ADC (cm2/sec) VDP (%) ADC (cm2/sec)
FEV1* 20.84 (,.0001) [,.0001] 20.75 (.0007) [.002] 20.89 (,.0001) [.001] 20.67 (0.01) [.01]
FEV1/FVC 20.84 (,.0001) [.001]
† 20.86 (,.0001) [.001] 20.95 (.0001) [.001]† 20.77 (.002) [.004]
DLCO* 20.83 (.0001) [.001]
‡ 20.95 (,.0001) [.001]§ 20.92 (,.0001) [.001]‡ 20.93 (,.0001) [.001]||
Note.—Data are Pearson correlation coefficients. Numbers in parentheses are P values. Numbers in brackets are Holm-Bonferroni–adjusted P values. Significant difference (P , .05) between 3He and 
129Xe MR imaging correlation coefficients for each r value was calculated by using the Fisher z9 transformation.
* Data are percentage predicted values.
† The relationship between VDP and FEV1/FVC was significantly stronger for 
129Xe imaging (P = .01).
‡ Available for 15 subjects.
§ Available for 13 subjects.
|| Available for 10 subjects.
Figure 3
Figure 3: Graphs show relationships between ADCs obtained with 3He and 129Xe MR imaging and CT 
measurements. A, Areas with attenuation values in the 15th percentile (HU15) at CT show significant 
correlation with 3He ADC (r = 20.91, P = .0003; r 2 = 0.83, P = .0003; y = 2225 3 2839) and 129Xe 
ADC (r = 20.91, P = .0003; r 2 = 0.82, P = .0003; y = 21815 3 2803). B, Relative areas with atten-
uation values of less than 2950 HU at CT (RA
950
) show significant correlation with 3He ADC (r = 0.90,  
P = .0005; r2 = 0.80, P = .0005; y = 105 3 232) and 129Xe ADC (r = 0.87, P = .001; r 2 = 0.76, P = 
.001; y = 821 3 247). Dashed lines = 95% confidence intervals of regression line.
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moderate-to-severe COPD. Therefore, 
caution should be exercised in extrap-
olating these results to the general 
COPD population and, more specifi-
cally, patients with mild and very severe 
disease. We must also acknowledge 
that because all of these measurements 
and tests were performed in the same 
small subject group, extrapolation of 
these results to a general COPD popu-
lation cannot be confirmed until studies 
with larger sample sizes are performed. 
Another limitation is the difference in 
pulse sequences used for 3He and 129Xe 
MR imaging. However, results obtained 
with non-DW images acquired with 2D 
fast gradient-recalled echo sequences 
were in agreement with those from 
2D 3He and 3D 129Xe MR imaging, in-
dicating that there was no difference 
between 3He and 129Xe VDPs for the 
healthy volunteers. For patients with 
COPD, however, 129Xe VDP was greater 
than 3He VDP.
In summary, there was a strong 
correlation between 129Xe and 3He 
ADCs in healthy volunteers and pa-
tients with COPD but significant differ-
ences in 129Xe and 3He gas distribution 
in COPD, reflecting differences in the 
gases as well as physiologic and/or ana-
tomic abnormalities in COPD not seen 
in healthy volunteers.
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3He and 129Xe ADCs and DLCO and CT 
measurements. The relationship be-
tween 129Xe ADC and spirometric mea-
surements for b = 12 sec/cm2 has been 
previously reported (39) in patients 
with COPD and healthy volunteers, and 
similar correlation coefficients for the 
percentage predicted FEV1 and FEV1/
FVC were observed herein. However, 
we reported slightly higher ADCs for 
both healthy volunteers and ex-smokers 
with COPD, and this may be due to the 
differences in the inspired gas mixtures 
between the two different studies. We 
note that a 1.0-L 129Xe dose was used 
in the previously published study and, 
as shown in Table E1 (online), the es-
timated diffusion coefficient of 129Xe in 
air was 0.138 cm2/sec whereas that of 
129Xe diluted with 4H and air as used 
in this study was 0.211 cm2/sec. In ad-
dition, the strong correlations between 
129Xe with 3He ADC and the strong and 
similar correlations between both 129Xe 
and 3He ADC with CT measurements 
of emphysema suggest that 129Xe DW 
imaging with b = 12 sec/cm2 is sensitive 
to lung microstructural abnormalities. 
The comparable results we observed 
with 3He and 129Xe ADCs suggest that 
both methods are probing similar spa-
tial dimensions, which is important be-
cause the choice of DW gradient can 
influence the measured ADC. We must 
also note that the patients with COPD 
investigated herein showed varying de-
grees of emphysema, with percentage 
predicted DLCO values ranging from 
17% to 67%, indicating that 129Xe MR 
imaging as used in this study provided 
a way to measure varying degrees of 
emphysema. Future studies comparing 
129Xe ADC with different b values to 
3He ADC and CT emphysema measure-
ments, as well as comparing the 129Xe 
ADC anterior-posterior gradients with 
different b values, which has been pre-
viously shown by using 3He MR imaging 
to change following treatment in COPD 
(36), are required to determine the dif-
ferences that DW provides for probing 
the lung microstructure.
We recognize that this work was 
limited by the small number of sub-
jects and the fact that the analysis 
was restricted mainly to patients with 
beyond a realistic single-breath-hold 
time. To try to better understand the 
properties of the two gases inhaled, we 
generated theoretical diffusion coeffi-
cients as previously described (42) for 
3He diluted with N2 and air and 
129Xe 
diluted with 4He and air and compared 
these to the theoretical self-diffusion 
coefficient of air. Taken together, these 
results indicated that air has a similar 
estimated diffusion coefficient as 129Xe 
diluted with 4He and air (within 3%) 
and that both diffusion coefficients are 
much lower than the estimated diffu-
sion coefficient of 3He diluted with N2 
and air. Although the exact etiology 
that may explain the differences be-
tween the gas distributions at 129Xe 
and 3He MR imaging in COPD has not 
yet been established, it is possible that 
the differences in diffusion coefficients 
might provide part of the reason for 
these observed differences and that 
different gas mixtures may be helpful 
in probing different airway and paren-
chymal abnormalities. For example, the 
larger 129Xe VDP in COPD might reflect 
the fact that airway narrowing is less 
easily penetrated by 129Xe-4He.
Second, we reported significant and 
similar correlations between 3He and 
129Xe VDP and spirometric measure-
ments for all subjects; however, the 
correlation coefficient was significantly 
stronger between 129Xe VDP and FEV1/
FVC. We note that, during expiration in 
COPD, airway narrowing is caused by a 
combination of many factors, including 
small-airway wall thickening and oblit-
eration and collapse of airways second-
ary to the loss of lung tissue within the 
lungs. FEV1/FVC is reduced in subjects 
with severe COPD and asthma and has 
been reported to be sensitive to airway 
narrowing and bronchoconstriction 
(58). The finding that the correlation 
of VDP with FEV1/FVC was stronger 
with 129Xe than with 3He lends support 
to the notion that the differences in the 
diffusion coefficients of the gases might 
be helpful in probing different airway 
and parenchymal abnormalities.
Finally, we also reported strong and 
significant correlations between 3He and 
129Xe ADCs in the same subjects and 
similar correlation coefficients between 
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